Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2015-11-16 Regulatory Filings
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions the announcement of a press release about a new product development program. There are no financial statements or detailed financial data included, and the document length is only 2501 characters, indicating it is a brief announcement rather than a full report. The document does not contain quarterly or annual financial results, audit information, or management discussion. It is not a certification or officer attestation. The content fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like earnings release or management report.
2015-11-16 English
FORM 10-Q
Interim / Quarterly Report 9M 2015
2015-11-16 English
FORM S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans. It includes details about the securities to be registered, incorporation by reference of other SEC filings, indemnification provisions, and other regulatory disclosures. It is not a financial report like an Annual Report (10-K) or Quarterly Report (IR), nor is it an announcement or proxy statement. Form S-8 filings are regulatory filings related to securities registration and employee plans. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a full filing, not a brief announcement or certification.
2015-11-12 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2015-10-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 8, 2015. It announces that Titan Pharmaceuticals received approval to list its common stock on the NASDAQ Capital Market. The content is an announcement of a corporate event (listing approval) and includes a press release as an exhibit. The document is short (2448 characters) and does not contain financial statements or detailed financial data. It is not a full financial report, earnings release, or management discussion. It is also not a regulatory certification or officer attestation. The primary purpose is to inform about a capital market listing event, which fits best under a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2015-10-09 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration, not an announcement of voting results, capital changes, or other categories. The document length is short (2959 characters) and contains no financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2015-10-07 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.